Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Barrett Esophagus × Docosahexaenoic Acids × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Gastrointestinal 1

Conditions

Obesity 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Overweight 1 Non-alcoholic Fatty Liver Disease 1 Neoplasms 1 Infections 1 Barrett Esophagus 1

Interventions

Esomeprazole 3 rofecoxib 1 Prednisolone 1 Omeprazole 1 Lansoprazole 1 Gastropexy 1 Fundoplication 1 Docosahexaenoic Acids 1 Dexlansoprazole 1 Cryotherapy 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01733147 2022-01-11

Modulation of Esophageal Inflammation in Barrett's Esophagus by Omega-3 Fatty Acids

Mayo Clinic

Phase 4 Completed

60 enrolled 6 charts

GastrointestinalOther

Barrett Esophagus, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡